scholarly journals Clinical Evaluation of Laparoscopic Gastrectomy for Gastric Cancer in the Elderly Patients Using POSSUM and E-PASS Scoring System

Author(s):  
Takeshi Matsutani ◽  
Itsuro Fujita ◽  
Yoshikazu Kanazawa ◽  
Nobutoshi Hagiwara ◽  
Tsutomu Nomura ◽  
...  
2015 ◽  
Vol 30 (4) ◽  
pp. 1380-1387 ◽  
Author(s):  
Muneharu Fujisaki ◽  
Toshihiko Shinohara ◽  
Nobuyoshi Hanyu ◽  
Susumu Kawano ◽  
Yujiro Tanaka ◽  
...  

2016 ◽  
Vol 31 (6) ◽  
pp. 2706-2709
Author(s):  
Muneharu Fujisaki ◽  
Toshihiko Shinohara ◽  
Nobuyoshi Hanyu ◽  
Susumu Kawano ◽  
Yujiro Tanaka ◽  
...  

2021 ◽  
Author(s):  
Omer Yalkin ◽  
Nidal Iflazoglu ◽  
Olgun Deniz ◽  
Mustafa Yener Uzunoglu ◽  
Ezgi Isil Turhan

Abstract Objective: The aim of this study was to clarify the prognostic value of the pathological lymph node ratio for elderly and non-elderly gastric cancer patients and to evaluate whether there is a difference in the survival of patients with the same LNR (Lymph Node Ratio).Materials and Methods: A total of 222 patients diagnosed with locally advanced gastric cancer and who underwent gastrectomy were included. The patients were divided into two groups according to age. Clinicopathological properties of the two groups were compared. Potential prognostic factors affecting survival were analyzed. Subsequently, the effect of lymphadenectomy and LNR on survival in both groups was evaluated. Results: Significant differences were detected in terms of the location of primary lesions, hemoglobin and albumin levels between elderly patients and non-elderly patients (p < .05). Overall survival (OS) was significantly worse in elderly patients (22 months vs. 67 months, p<0.001). The survival rates in elderly patients were significantly lower from those of non-elderly in the subgroup LNR Stage 2 (12.1% vs. 47.9 %, P = 0.004) and LNR Stage 3 classification (9.1% vs. 34.1%, P = 0.039). LNR was found to be significant for OS with a cut-off point of 0.18. Conclusion: A survival difference was found between the elderly and non-elderly patients with the same LNR. LNR was found to be an independent factor for survival especially in elderly patients. Survival was found to be further decreased in elderly patients compared to non-elderly patients with increasing LNR.


2020 ◽  
Vol 44 (7) ◽  
pp. 2332-2339
Author(s):  
Yuki Ushimaru ◽  
Yukinori Kurokawa ◽  
Tsuyoshi Takahashi ◽  
Takuro Saito ◽  
Kotaro Yamashita ◽  
...  

2012 ◽  
Vol 23 ◽  
pp. ix229
Author(s):  
D. Egamberdiev ◽  
M. Djuraev ◽  
S. Khudayorov ◽  
O. Nematov ◽  
A. Babaev ◽  
...  

2017 ◽  
Vol 35 (4_suppl) ◽  
pp. 45-45 ◽  
Author(s):  
Aya Sugimoto ◽  
Tsutomu Nishida ◽  
Kei Takahashi ◽  
Kaori Mukai ◽  
Tokuhiro Matsubara ◽  
...  

45 Background:There is little evidence if chemotherapy (CT) offer survival benefit for elderly patients (EP) with advanced gastric cancer (AGC). Methods: This was a single-centre retrospective study. A total of 118 patients with AGC were hospitalized at our hospital from April 2012 to June 2016. Of them, EP older than 75 years with AGC were eligible for inclusion in the study. Basically, the treatment strategy, chemotherapy (CT) or best supportive care (BSC) were comprehensively decided according to their background. We evaluate the risk factors for survival using the Cox proportional hazard model and explored the optimal indication for CT for EP. Results: Of 118 patients with AGC, 47 patients were enrolled as EP [63% men; mean age, 81 years]. Of EP, 26 patients (55%) received CT and 21 patients received BSC. As first-line CT, 13 patients received S1 monotherapy, the others treated with combination agents. The median overall survival time (MST) was 138 days. There was no significant difference between CT and BSC group (172 vs. 118 days, p = 0. 1087). Univariate analysis revealed the following 5 factors for poor prognosis were significant (defined as p-value < 0.1): Performance status (PS) 3a 2 (HR3.7, 95% CI: 1.5-8.5), C-reactive protein levels 3a 1mg/dL (HR4.0, 95% CI: 1.8-9.4), albumin level < 3g/dL (HR2.1, 95% CI: 1.1-4.3), neutrophil/lymphocyte ratio (NLR) 3a 4 (HR3.7, 95% CI: 1.7-8.5), and diffuse type (HR1.8, 95% CI: 0.9-3.8). As each poor risk factor of 5 and age factor 3a 80 years represents point 1, we calculated total points (0-6) for each patient. Median total points of CT and BSC were 2 and 4, respectively (p = 0.0196). Therefore, we set cut-off point of 3. Then, EP with a total point of 3 and more were classified as high risk group (HR: N = 25) and the others were as low risk group (LR: N = 22). There was significantly longer MST in LR than HR (all EP; 457 vs 105 days, HR: 0.23, p = 0.0002 and EP with CT; 232 vs 113 days, HR:0.26, p = 0.0085). Conclusions: Our findings using the scoring system including 6 factors suggest that EP with a total point 3 and more, were poor prognosis and may not receive benefit from CT for AGC. When judging indication for CT in EP with AGC, this scoring system may be useful, and in case of LR (total point 0-2) may be considered an indication for CT.


2016 ◽  
Vol 19 (3) ◽  
pp. 97-101
Author(s):  
Hyo Jung Ko ◽  
Ki Hyun Kim ◽  
Si Hak Lee ◽  
Cheol Woong Choi ◽  
Su Jin Kim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document